Ferabright is the first and only iron-based contrast agent for MRI in the brainWoburn, MA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that FerabrightTM ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

The FDA's expanded clearances broaden the application of Bayer's Medrad MRXperion system across a wider range of MR settings.

CT Scans use X-rays for quick bone and Injury Imaging, While MRIs use magnets for soft tissue detail.

Globally, approximately 139 million people are expected to have Alzheimer's disease (AD) by 2050. Magnetic resonance imaging (MRI) is an important tool for identifying changes in brain structure that ...

The Center for Neuroscience Imaging Research (CNIR) in the Institute of Basic Science (IBS), Suwon, Korea, is developing new neuroimaging approaches to explore biophysics, physiology, and biology, and ...

With AiMIFY ® set to reinforce Bracco's core MRI portfolio in clinical practice and the Avicenna.AI collaboration extending ...

Editor’s note: On Sept. 25, 2025, the authors retracted this article from Science after concerns were raised in 2023 about the study’s methods and data analysis. Upon reanalyzing the data, the authors ...

Leesburg, VA, December 21, 2022—Findings from an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) have highlighted potentially substantial cost savings by reducing the ...